KR920008039A - (IR,5S,6S)- 2-[(6,7-디히드로-5H-피라졸로[1,2-a][1,2,4]트리아졸륨-6-일)]티오-6- [(R)-1-히드록시 에틸]-1-메틸-카르바페넴-3-카르복실레이트 및 그의 출발물질의 제조방법 - Google Patents
(IR,5S,6S)- 2-[(6,7-디히드로-5H-피라졸로[1,2-a][1,2,4]트리아졸륨-6-일)]티오-6- [(R)-1-히드록시 에틸]-1-메틸-카르바페넴-3-카르복실레이트 및 그의 출발물질의 제조방법 Download PDFInfo
- Publication number
- KR920008039A KR920008039A KR1019900022756A KR900022756A KR920008039A KR 920008039 A KR920008039 A KR 920008039A KR 1019900022756 A KR1019900022756 A KR 1019900022756A KR 900022756 A KR900022756 A KR 900022756A KR 920008039 A KR920008039 A KR 920008039A
- Authority
- KR
- South Korea
- Prior art keywords
- formula
- dihydro
- compound
- pyrazolo
- general formula
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
- C07D477/10—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
- C07D477/12—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
- C07D477/16—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
- C07D477/20—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/04—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
내용 없음
Description
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음
Claims (9)
- 하기 일반식(Ⅱ)의 화합물을 하기 일반식(Ⅲ)의 6,7-디히드로-6-메르캅토-5H-피라졸로[1,2-a][1,2,4]트리아졸륨 유도체와 반응시켜 하기 일반식(Ⅳ)의 화합물을 수득한 다음, 얻어진 일반식(Ⅳ)의 화합물을 카르복실 보호기를 제거시켜 하기 일반식(Ⅰ)의 카르바페넴 화합물을 수득하는 것으로 구성된, 일반식(Ⅰ)의 (IR,5S,6S)-2-[(6,7-디히드로- 5H-피라졸로[1,2-a][1,2,4]트리아졸륨-6-일)]티오-6- [(R)-1-히드록시 에틸]-1- 메틸-카르바페넴-3-카르복실레이트 및 약학적으로 허용가능한 그으이 염의 제조방법.[상기식중, R1은 카르복실 보호기이고, R8는 아실기이고,은 음이온 전하이다]
- (a)하기 일반식(Ⅴ)의 6,7-디하드로-5H-피라졸로[1,2-a][1,2,4]트리아졸륨-6-일-디술피드를 환원시켜 하이 일반식(Ⅲ)의 6,7-디하드로-6-메르캅토-5H-피라졸로[1,2-a][1,2,4]트리아졸륨 유도체를 형성하고, (b)이어서, 얻어진 일반식(Ⅲ)의 화합물을 하기 일반식(Ⅱ)의 화합물과 반응시켜 하기 일반식(Ⅳ)의 화합물을 수득하고, (c)이어서, 얻어진 일반식(Ⅳ)의 화합물을 카르복실 보호기를 제거시켜 일반식(Ⅰ)의 카르바페넴 화합물을 수득하는 것으로 구성된, 제1항에 정의된 일반식(Ⅰ)의 (IR,5S,6S)-2-[(6,7-디히드로- 5H-피라졸로[1,2-a][1,2,4]트리아졸륨-6-일)]티오-6- [(R)-1-히드록시 에틸]-1- 메틸-카르바페넴-3-카르복실레이트 및 그의 출발물질의 제조방법.[상기식중, R1은 카르복실 보호기이고, R8는 아실기이고,은 음이온 전하이다]
- (a)하기 일반식(Ⅴ)의 피라졸리딘-4-일 -디술피드를 포름이미드산 에스테르와 반응시켜 하기 일반식(Ⅴ)의 6,7-디히드로-5H-피라졸로[1,2-a][1,2,4]트리아졸륨-6-일-디술피드를 수득하고, (b)얻어진 일반식(Ⅴ)의 화합물을 환원시겨 하기 일반식(Ⅲ)의 6,7-디히드로-6-메르캅토-5H-피라졸로[1,2-a][1,2,4]트리아졸륨 유도체를 형성하고, (c)얻어진 일반식(Ⅲ)의 화합물을 하기 일반식(Ⅱ)의 화합물과 반응시켜 하기 일반식(Ⅳ)의 화합물을 수득하고, (d)이어서, 얻어진 일반식(Ⅳ)의 화합물을 카르복실 보호기를 제거시켜 일반식(Ⅰ)의 카르바페넴 화합물을 수득하는 것으로 구성된, 제1항에 정의된 일반식(Ⅰ)의 (IR,5S,6S)-2-[(6,7-디히드로- 5H-피라졸로[1,2-a][1,2,4]트리아졸륨-6-일)]티오-6- [(R)-1-히드록시 에틸]-1- 메틸-카르바페넴-3-카르복실레이트 및 약학적으로 허용 가능한 그의 염의 제조방법[상기식중, R1은 카르복실 보호기이고, R8는 아실기이고,은 음이온 전하이다]
- 하기 일반식(Ⅵ)의 피라졸리딘-4-일-디술피드 또는 그의 염.
- 하기 일반식(Ⅴ)의 6,7-디히드로-5H-피라졸로[1,2-a][1,2,4]트리아졸륨-6-일-디술피드.[식중,은 음이온 전하이다]
- 하기 일반식(Ⅲ)의 6, 7-디히드로-6-메르캅토-5H-피라졸로〔1,2-a〕〔1,2,4〕트리아졸륨 유도체.〔식중, X은 음이온 전하이다〕
- 하기 일반식(Ⅵ)의 피라졸리딘-4-일-디술피드 또는 그의 염을 포름이미드 산 에스테르와 반응시켜 일반식(ⅴ)의 화합물을 수득하는 것으로 구성된, 제5항에 정의된 일반식(ⅴ)의 6,7-디히드로-5H-피라졸로〔1,2-a〕〔1,2,4〕트리아졸륨-6-일-디술피드의 제조방법.
- 하기 일반식(ⅴ)의 6,7-디히드로-5H-피라졸로〔1,2-a〕〔1,2,4〕트리아졸륨-6-일-디술피드를 환원시켜 일반식(Ⅲ)의 화합물을 수득하는 것으로 구성된, 제6항에 정의된 일반식(Ⅲ)의 6,7-디히드로-5H-피라졸로〔1,2-a〕〔1,2,4〕트리아졸륨 유도체의 제조방법.〔식중, X은 음이온 전하이다.〕
- 하기 일반식(Ⅵ)의 피라졸리딘-4-일-디술피드 또는 그의 염을 포름이미드산 에스테르와 반응시켜 하기 일반식(ⅴ)의 6,7-디히드로-5H-피라졸로〔1,2-a〕〔1,2,4〕트리아졸륨-6-일-디술피드를 수득한 다음, 얻어진 일반식(Ⅴ)의 화합물을 환원시켜 일반식(Ⅲ)의 화합물을 형성하는 것으로, 구성된 제6항에 정의된 일반식(Ⅲ)의 6,7-디히드로-6-메르캅토-5H-피라졸로〔1,2-a〕〔1,2,4〕트리아졸륨 유도체의 제조방법.〔식중, X은 음이온 전하이다〕※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP27242690 | 1990-10-12 | ||
JP27242790 | 1990-10-12 | ||
JP272426/90 | 1990-10-12 | ||
JP27242890 | 1990-10-12 | ||
JP272427/90 | 1990-10-12 | ||
JP272428/90 | 1990-10-12 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR920008039A true KR920008039A (ko) | 1992-05-27 |
KR970011387B1 KR970011387B1 (ko) | 1997-07-10 |
Family
ID=27335996
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019900022756A KR970011387B1 (ko) | 1990-10-12 | 1990-12-31 | (1R, 5S, 6S)-2-〔(6, 7-디히드로-5H-피라졸로〔1,2-a〕〔1,2,4)트리아졸륨-6-일)〕티오-6-〔(R)-1-히드록시에틸〕-1-메틸-카르바페넴-3-카르복실레이트 및 그의 출발물질의 제조방법 |
Country Status (13)
Country | Link |
---|---|
EP (1) | EP0480100B1 (ko) |
KR (1) | KR970011387B1 (ko) |
AT (1) | ATE144260T1 (ko) |
AU (1) | AU627970B2 (ko) |
CA (1) | CA2033479C (ko) |
DE (1) | DE69028920T2 (ko) |
DK (1) | DK0480100T3 (ko) |
ES (1) | ES2093010T3 (ko) |
FI (1) | FI906464A (ko) |
GR (1) | GR3021807T3 (ko) |
IL (1) | IL96843A (ko) |
NO (1) | NO176102C (ko) |
TW (1) | TW239142B (ko) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0776574A (ja) * | 1993-09-06 | 1995-03-20 | Wako Pure Chem Ind Ltd | ジスルフィド化合物の製造法 |
CN101768174B (zh) * | 2009-01-07 | 2012-08-08 | 四川科伦药业股份有限公司 | 一种比阿培南的制备方法 |
CN103497207B (zh) * | 2011-01-29 | 2015-09-30 | 正大天晴药业集团股份有限公司 | 比阿培南b型结晶 |
CN102731534B (zh) * | 2011-04-13 | 2016-02-03 | 石药集团中奇制药技术(石家庄)有限公司 | 一种比阿培南的制备方法 |
CN102268025A (zh) * | 2011-07-15 | 2011-12-07 | 海南美兰史克制药有限公司 | 一种比阿培南化合物及其制法 |
CN103965220A (zh) * | 2013-02-01 | 2014-08-06 | 上海医药工业研究院 | 一种制备高纯度比阿培南的方法 |
CN103570750A (zh) * | 2013-11-15 | 2014-02-12 | 安徽悦康凯悦制药有限公司 | 一种比阿培南的制备工艺 |
CN105481883A (zh) * | 2015-10-26 | 2016-04-13 | 山东鲁抗生物制造有限公司 | 一种高纯度比阿培南的合成方法 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IE851586L (en) * | 1984-07-02 | 1986-01-02 | Interchem Internat S A | I methylcarbapenems having a 2-quaternary¹heteroarylalkylthio substituent |
JPS6425779A (en) * | 1987-04-11 | 1989-01-27 | Lederle Japan Ltd | (1r,5s,6s)-2-substituted-thio-6-((r)-1-hydroxyethyl)-1-methyl -carbapenem-3-carboxylic acid derivative |
US5102877A (en) * | 1989-04-28 | 1992-04-07 | Fujisawa Pharmaceutical Co., Ltd. | 1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid compounds |
JPH02292269A (ja) * | 1989-05-06 | 1990-12-03 | Lederle Japan Ltd | 活性アミド化合物 |
-
1990
- 1990-12-28 DE DE69028920T patent/DE69028920T2/de not_active Expired - Lifetime
- 1990-12-28 AT AT90125730T patent/ATE144260T1/de not_active IP Right Cessation
- 1990-12-28 EP EP90125730A patent/EP0480100B1/en not_active Expired - Lifetime
- 1990-12-28 NO NO905625A patent/NO176102C/no not_active IP Right Cessation
- 1990-12-28 DK DK90125730.3T patent/DK0480100T3/da active
- 1990-12-28 ES ES90125730T patent/ES2093010T3/es not_active Expired - Lifetime
- 1990-12-31 KR KR1019900022756A patent/KR970011387B1/ko not_active IP Right Cessation
- 1990-12-31 CA CA002033479A patent/CA2033479C/en not_active Expired - Lifetime
- 1990-12-31 IL IL9684390A patent/IL96843A/en not_active IP Right Cessation
- 1990-12-31 FI FI906464A patent/FI906464A/fi not_active Application Discontinuation
-
1991
- 1991-01-02 TW TW080100039A patent/TW239142B/zh active
- 1991-01-02 AU AU68628/91A patent/AU627970B2/en not_active Expired
-
1996
- 1996-11-28 GR GR960403198T patent/GR3021807T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
NO905625D0 (no) | 1990-12-28 |
AU627970B2 (en) | 1992-09-03 |
NO176102B (no) | 1994-10-24 |
EP0480100A2 (en) | 1992-04-15 |
FI906464A0 (fi) | 1990-12-31 |
DE69028920D1 (de) | 1996-11-21 |
CA2033479C (en) | 2001-01-23 |
DK0480100T3 (da) | 1996-11-18 |
GR3021807T3 (en) | 1997-02-28 |
EP0480100B1 (en) | 1996-10-16 |
IL96843A0 (en) | 1991-09-16 |
EP0480100A3 (en) | 1992-10-21 |
NO176102C (no) | 1995-02-01 |
IL96843A (en) | 1995-07-31 |
TW239142B (ko) | 1995-01-21 |
AU6862891A (en) | 1992-06-11 |
KR970011387B1 (ko) | 1997-07-10 |
NO905625L (no) | 1992-04-13 |
CA2033479A1 (en) | 1992-04-13 |
DE69028920T2 (de) | 1997-02-13 |
ATE144260T1 (de) | 1996-11-15 |
FI906464A (fi) | 1992-04-13 |
ES2093010T3 (es) | 1996-12-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR830006219A (ko) | 아미노산 유도체의 제조방법 | |
CA2127047A1 (en) | Preparation of astaxanthin, novel intermediates therefor and the preparation thereof | |
AU643489B2 (en) | Antibacterial agents - II | |
KR870007128A (ko) | 8-알콕시퀴놀론 카복실산 유도체의 제조방법 | |
KR920006358A (ko) | 1-메틸카르바펜엠 유도체 및 그의 제조방법 | |
TW240249B (ko) | ||
KR920008039A (ko) | (IR,5S,6S)- 2-[(6,7-디히드로-5H-피라졸로[1,2-a][1,2,4]트리아졸륨-6-일)]티오-6- [(R)-1-히드록시 에틸]-1-메틸-카르바페넴-3-카르복실레이트 및 그의 출발물질의 제조방법 | |
KR880012604A (ko) | (1r,5s,6s )-2-치환 티오-6[(r)-1-히드록시에틸]-1-메틸-카바페넴-3-카복실산 유도체 | |
KR880001677A (ko) | β-락탐 화합물, 그의 제조 방법, 이를 함유하는 세균 감염성 질병 치료용 약제 및 그의 합성을 위한 중간체 | |
AU575545B2 (en) | 6-hydroxyalkyl-penicillins | |
HU9301931D0 (en) | Process for the production of azabicyclo [2.2.2] octane-3-imines and thereof inrtermediers | |
EP1046634A4 (en) | METHOD FOR PRODUCING BETA-HALOGEN-ALPHA-AMINO-CARBONIC ACIDS, PHENYLCYSTEINE DERIVATIVES AND THEIR INTERMEDIATES | |
CA2293835A1 (en) | Stabilized carbapenem intermediates and synthetic use | |
ES8609238A1 (es) | Un procedimiento para preparar 4-acetoxi-3-hidroxietilazeti-zin-2-ona | |
IE792112L (en) | Process for the manufacture of 1,2,3-thiadiazol-5-yl ureas | |
AU548727B2 (en) | Beta-lactam acetic acid derivatives | |
ATE156134T1 (de) | Verfahren zur herstellung von alkylpolyglukosiden | |
IE890090L (en) | Process for preparing 1-alkyl-5-nitroimidazoles | |
KR910006294A (ko) | 피롤로피리미딘, 그의 제법 및 용도 | |
DE69211936T2 (de) | Verfahren zur Herstellung von niedrigem Alkyl-2-oxo-L-Gulonat | |
AU8309591A (en) | Process for producing aminomethanephosphonic acid and aminomethylphosphinic acids | |
NZ322485A (en) | Production of a salt of clavulanic acid using n-butanol or isobutanol as the solvent which contains 0.5-10% of water | |
KR910011777A (ko) | 피롤알데히드 유도체, 그의 제조방법 및 이 화합물을 함유하는 제약조성물 | |
AU3999493A (en) | Process for preparing tetronic acid alkyl esters | |
AU8938082A (en) | 3-chloro-pregnane and preparation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
G160 | Decision to publish patent application | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20101110 Year of fee payment: 14 |
|
EXPY | Expiration of term |